Biomarker ID | 1286 |
PMID | 24391718 |
Year | 2013 |
Biomarker | PDCD6IP; UBA52; BCAM; PABPC1; YWHAB; ANXA2; ATP1A1; ATP1B1; ATP1B3; BSG; CLIC1; ITGA6; F11R; ACTA2; ATP12A; CTNNB1; ENO1; HSPA5; KPNB1; PKM2; TPI1; ARF1; CD151; CXADR; HSP90AB3P; IQGAP1; PGK1; PRDX1; RAB10; RAP1A; TUBA1A; UGDH; |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Cell Lines |
Subjects | Humans |
Regulation | Upregulated in VCaP cell lines (log2 fold): Downregulated in VCaP cell lines (log2 fold): [] |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | VCaP vs PNT2C2 |
Type of Biomarker | Diagnostic |
Cohort | 2 immortalized primary prostate epithelial cells (PNT2C2 and RWPE- 1) and 2 PCa cell lines (PC346C and VCaP) were chosen for this study |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.05 |
Method Used | Mass spectrometry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Selected Genes validated on cell lines by Western Blotting |
Technical Name | PDCD6IP, UBA52, BCAM, PABPC1, YWHAB, ANXA2, ATP1A1, ATP1B1, ATP1B3, BSG, CLIC1, ITGA6, F11R, ACTA2, ATP12A, CTNNB1, ENO1, HSPA5, KPNB1, PKM2, TPI1, ARF1, CD151, CXADR, HSP90AB3P, IQGAP1, PGK1, PRDX1, RAB10, RAP1A, TUBA1A, UGDH |